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Abstract
The innate immune response is supposed to play an essential role in the control of amebic liver abscess (ALA), a severe form
of invasive amoebiasis due to infection with the protozoan parasite Entamoeba histolytica. In a mouse model for the disease,
we previously demonstrated that Ja18
-/- mice, lacking invariant natural killer T (iNKT) cells, suffer from more severe abscess
development. Here we show that the specific activation of iNKT cells using a-galactosylceramide (a-GalCer) induces a
significant reduction in the sizes of ALA lesions, whereas CD1d
2/2 mice develop more severe abscesses. We identified a
lipopeptidophosphoglycan from E. histolytica membranes (EhLPPG) as a possible natural NKT cell ligand and show that the
purified phosphoinositol (PI) moiety of this molecule induces protective IFN-c but not IL-4 production in NKT cells. The main
component of EhLPPG responsible for NKT cell activation is a diacylated PI, (1-O-[(28:0)-lyso-glycero-3-phosphatidyl-]2-O-
(C16:0)-Ins). IFN-c production by NKT cells requires the presence of CD1d and simultaneously TLR receptor signalling
through MyD88 and secretion of IL-12. Similar to a-GalCer application, EhLPPG treatment significantly reduces the severity
of ALA in ameba-infected mice. Our results suggest that EhLPPG is an amebic molecule that is important for the limitation of
ALA development and may explain why the majority of E. histolytica-infected individuals do not develop amebic liver
abscess.
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Introduction
Entamoeba histolytica the causative agent of human amebiasis is an
intestinal protozoan parasite that causes significant morbidity and
mortality worldwide [1]. The main symptoms associated with
ameba infection arise when the parasite breach the colonic
mucosa, leading to severe hemorrhagic colitis or the development
of extraintestinal abscesses, most commonly in the liver.
Interestingly, only a small proportion of individuals infected with
E. histolytica develop invasive amebiasis while the majority harbors
the parasite in the gut without clinical signs of disease [2,3]. From
in vitro studies as well as from animal models for experimental
amebic liver abscess (ALA) it is well documented that IFN-c plays
an important role in the early control of E. histolytica invasion. The
development of amebicidal activity by neutrophils and monocytes
in vitro is dependent on IFN-c [4–7]. Accordingly, the depletion of
IFN-c by monoclonal antibodies or the targeted disruption of the
IFN-c receptor in mice led to more severe tissue destructions of the
liver parenchyma in the mouse model for ALA [8,9]. Effector
lymphocytes with innate like functions such as cd–T cells, natural
killer cells or natural killer T (NKT) cells infiltrate into the center
of experimental ALA and thus can serve as a source for the
protective IFN-c in the early phase of abscess development.
Hence, mice deficient for cd-T cells, but more importantly,
Ja18
2/2 mice, lacking NKT-cells, have been shown to develop
considerably larger abscesses compared to respective controls [8].
NKT cells are involved in immune responses in a broad range of
diseases, including autoimmunity, allergy, cancer and infectious
diseases [10]. Murine NKT cell populations are heterogeneous
[11], but the majority expresses an invariant Va142Ja18 TCR
and therefore they are referred to as invariant NKT (iNKT) cells,
that unlike activation of conventional ab2T cells by antigenic
peptides, recognize glycolipids presented by the nonclassical
antigen presenting molecule CD1d. Upon ligation of their TCR,
PLoS Pathogens | www.plospathogens.org 1 May 2009 | Volume 5 | Issue 5 | e1000434iNKT cells can produce large amounts of a variety of cytokines with
sometimesoppositefunction,includingthepro-inflammatory IFN-c
as well as the anti-inflammatory IL-4, IL-10 and IL-13, which is
believed to instruct the development of subsequent immune
responses. The prototypical and by far most studied iNKT cell
antigen is the glycolipid a-galactosylceramide (a-GalCer), a marine
sponge glycolipid, which is a potent CD1d-restricted agonist widely
used for in vitro and in vivo experiments to decipher iNKT cell
function[12].Inrecentyears,ithas been shownthat iNKTcellscan
be activated directly by recognition of microbial glycolipids
presented by CD1d or, indirectly by soluble mediators such as IL-
12 and/or by recognition of endogenous ligands, both provided by
dendritic cells (DC) s2stimulated via Toll-like receptors (TLRs)
[10,13]. In addition to a-GalCer, diverse natural CD1d ligands that
stimulate iNKT cells have been identified in various microorgan-
sims[14–18].Accordingly,micelackingNKTcellsandinparticular
iNKT cells, have an increased susceptibility to various bacterial,
fungal, and parasitic infections [8,15,17,19].
Similar to other protozoa, E. histolytica exposes on its surface a
complex GPI-anchored glycoconjugate, designated E. histolytica
lipopeptidophosphoglycan (EhLPPG) [20]. As virulent and non-
virulent amebae differ in the amount and the antigenicity of their
LPPG these molecules have been associated with pathogenicity
[21–24]. The structural analysis of EhLPPG revealed the presence
of the Gal1Man2GlcN-myo-inositol motif linked to a phosphoserine
backbone substituted by the linear carbohydrate chains [Glca1-
6]nGlcb1-6Gal. Although a lipid anchor was proposed for this
molecule, evidence concerning the structure of the lipid has not
been provided so far. Thus, information is lacking whether this
structure may facilitate a CD1d restricted activation of NKT cells
in a CD1d restricted manner. However, toll-like receptor
pathways were involved in the induction of IL-12, IL-8, IL-10
and TNFa by EhLPPG [25].
The study presented here was aimed to further investigate the
role of NKT cells in the development of ALA, to isolate and
characterize the structure of a potential natural ligand from E.
histolytica trophozoites and to analyse the mechanism of NKT cell
activation by dendritic cells presenting EhLPPG.
Results
Control of amebic liver abscess requires presentation of
glycolipids by CD1d
In a previous study we have shown that mice lacking Va14-Ja18
iNKT cells have a reduced capacity to control experimentally
induced amebic liver abscess (ALA). The lack of control in these
knock out mice was evidenced by substantially larger abscess sizes
and increased re-isolation rates of E. histolytica trophozoites from
the liver lesions when compared to wild type controls [8]. To
further investigate the role of iNKT cells in the control of ALA, we
specifically activated iNKT cells by using the non-physiological
ligand a-GalCer. Wild-type C57BL/6 mice were treated with a
single dose of a-GalCer, 24 h prior to ameba challenge. This
treatment resulted in a significant reduction of ALA lesions
(p,0.003). In contrast, ALA in CD1d
2/2 mice, lacking iNKT and
dNKT cells, were significantly increased, irrespectively whether or
not treated with a-GalCer (p,0.006) (Fig. 1). The results indicate
the importance of NKT cells in the control of abcess formation.
Isolation of LPPG from E. histolytica trophozoites
The finding that CD1d is required to limit ALA development
suggested that an ameba glycolipid that is presented by CD1d and
which is able to activate iNKT cells is involved. A likely candidate
is the E. histolytica LPPG (EhLPPG), which is present in
considerable quantities on the surface of E. histolytica trophozoites.
Accordingly, EhLPPG was isolated using an adaptation of the
original reported method [26]. The EhLPPG recovered from the
aqueous phase after hot phenol-water extraction was initially
characterized by 12% SDS-PAGE gels and was visualized by
different staining procedures (Fig. 2A). The purified EhLPPG
yielded a negative staining with colloidal Coomassie-blue (lane 2),
which detects as low as 30 ng of protein content. Positive reaction
with the periodic acid Schiff (PAS) reagent (lane 3) or silver nitrate
(lane 4) evidenced a high degree of glycosylation of the molecule
Figure 1. Role of NKT cells in the control of ALA in mice. Mice
treated with a- G a l C e ro rm i c el a c k i n gC D 1 d( C D 1 d
2/2)w e r e
intrahepatically infected with virulent E. histolytica trophozoites. Seven
days p.i. animals were sacrificed and sizes of liver abscesses determined.
Bars represent sizes of abscess scores relative to those of wildtype
c o n t r o lm i c e( W T ) .R e s u l t sw e r eo b t a i n e df r o m3i n d e p e n d e n t
experiments comprising 5 to 7 animals each (statistics: Mann-Whitney
U test).
doi:10.1371/journal.ppat.1000434.g001
Author Summary
Amoebiasis is a widespread human parasitic disease
caused by the intestinal protozoan Entamoeba histolytica.
There are two major clinical manifestations of the disease,
amebic colitis and amebic liver abscess. Interestingly, only
a small proportion of E. histolytica-infected individuals
develop invasive disease, whereas the majority harbors the
parasite within the gut without clinical symptoms. So far,
cells of the innate immune system have been described to
constitute the main host defense mechanism for the
control of amoebiasis, relying largely on the early
production of interferon-c (IFN-c), a protein, which
activates macrophages to kill microorganisms including
parasites. However, the IFN-c-producing cells as well as the
amebic antigen involved in the activation have not been
identified. Here we demonstrate that mice challenged with
live E. histolytica, and which are deficient of a specific
lymphocyte population known as natural killer T cells (NKT
cells), have a reduced capacity to control ameba infection
and develop much larger amebic liver abscesses compared
to normal mice. In addition, we isolated a molecule from
the surface membrane of E. histolytica, which constitutes a
lipopeptidophosphoglycan, and which activates NKT cells
for the production of protective IFN-c. Thus, our study
provides a mechanism for the innate control of ameba
invasion that might explain why the majority of E.
histolytica-infected individuals do not develop amebic
disease.
E. histolytica Amebic liver abscess NKT
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between 97–200 kDa and 30–65 kDa, which was in agreement
with previous reports [23,27]. The presence of EhLPPG was
further confirmed by a Western-blot developed with EH5 (lane 5),
a monoclonal antibody specific for EhLPPG [28].
Induction of IFN-c by EhLPPG
In order to examine whether the purified EhLPPG was able to
stimulate lymphocytes from wild-type C57BL/6 mice in vitro,
antigen-presenting cells (APC) were generated and pulsed with a-
GalCer or purified EhLPPG prior to co-cultivation with isolated
liver or spleen lymphocytes. Supernatants were analysed for the
presence of IFN-c and IL-4, respectively. Stimulation of spleen or
liver lymphocytes with a-GalCer or EhLPPG resulted in
significant IFN-c production (Fig. 2B). However, similar to
recently described microbial glycolipids [17], the stimulation with
EhLPPG reached only 30–50% of the IFN-c levels induced by a-
GalCer, possibly due to the exceptional strong affinity of the non-
physiological ligand a-GalCer [29]. In contrast to a-GalCer,
EhLPPG-induced lymphocytes did not produce significant
amounts of IL-4 (Fig. 2C). The LPS content in the amebic
EhLPPG preparations was below 0.25 EU/ml at an EhLPPG
concentration of 2 mg/ml that induced significant levels of IFN-c.
This LPS concentration did not induce cytokine production in
control experiments (data not shown).
Isolation and structural characterization of the
phosphatidylinositol moiety from EhLPPG
To further characterize the portion of EhLPPG that might be
responsible for lymphocyte activation, and in particular to
determine whether the phosphatidylinositol moiety of the GPI
anchor from EhLPPG (EhPI) is involved, EhPI was separated from
EhLPPG after cleavage by nitrous acid deamination. HPTLC
analyses demonstrated the presence of two products, designated
EhPIa and EhPIb, respectively (Fig. 3A). These bands were
isolated and analyzed by GC-MS after methanolysis and
peracetylation in order to determine the chemical composition.
Both EhPIa and EhPIb contained glycerol (Gro), Inositol (Ins), as
well as the fatty acids 30:1, 28:0 and 16:0, respectively, the latter
being present only in minor amount in EhPIa. ESIFT-ICRMS
mass spectrometry revealed the presence of two prominent
pseudomolecular ions at m/z 765.49 and m/z 739.47 in EhPIa,
and at m/z 1003.72 and m/z 977.70 in EhPIb, evidencing a
difference of [M]+26 m/z in both cases. The most abundant ions
in EhPIa and EhPIb at m/z 739.47 and m/z 977.70, respectively,
corresponded to the molecules containing 28:0, whereas the ions
Figure 2. EhLLPG purified from membranes of E. histolytia
trophozoites stimulates production of IFN-c but not of IL-4 by
splenocytes and liver lymphocytes. (A) EhLPPG was separated by a
12% SDS-PAGE and developed by the following staining procedures:
colloidal Coomassie (lane 2), periodic acid-Schiff staining (lane 3), a
modified silver nitrate staining (lane 4) [61] and a Western-blot of
EhLPPG developed with mAb EH5 (lane 5) [28]. A low molecular weight
protein standard (BioRad), stained with colloidal Coomassie, is shown in
lane 1. The negative stain in lane 2 revealed the abscence of major
protein content, a positive staining in lane 3 and 4 evidenced the high
glycosylation of the molecule and the detection by EH5 in lane 5
proved the identity of E. histolytica LPPG. (B,C) APC (1x10
5) were pulsed
for 3 h with 2 mg a-GalCer or EhLPPG prior to co-cultivation with spleen
or gradient separated liver lymphocytes (4x10
5). Supernatants were
taken after 48 h and tested for the presence of IFN-c (B) and IL-4 by
ELISA (C). IFN-c produced compared to DMSO control
*( p,0.05);
**( p,0.005),
***( p,0.001); Mann Whitney U-test. The results were
obtained from experiments repeated at least 5 times.
doi:10.1371/journal.ppat.1000434.g002
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the molecules containing 30:1 (Fig. 3B). The fine structural
characteristics of both molecules were deduced after ESI-IRMPD
experiments (Fig. 3C). For EhPIa, the presence of the daughter ion
at m/z 241.0 (inositol-1,2-cyclic phosphate) identified the parent
ion as a PI and further indicated that the inositol ring was not
acylated at the position 2 [30]. The additional presence of only
one fatty acid carboxylate ion at m/z 449.4 (30:1) and the
abundant presence of the ion at m/z 153.0 (cyclic glycerophos-
phate) identified this PI as a lyso-acyl anchor [31]. The ions at m/z
585.4 and m/z 315.0 corresponded to P+Gro+30:1 and In-
s+P+Gro, respectively. In the case of EhPIb, the virtual absence of
the ion at m/z 241.0 and the presence of the pseudomolecular ions
at m/z 585.4 (showing the loss of the Ins+16:0 fragment) as well as
at m/z 479.2 (P+Ins+16:0), demonstrated a substitution with 16:0
at position 2 of the Ins. Acylation of inositol was the only structural
feature that differentiated EhPIb from EhPIa. Similar to EhPIa,
the abundant presence of the ion at m/z 153.0 in EhPIb and the
strong fatty acid carboxylate ion at m/z 449.4 (30:1), indicated a
lyso-acyl anchor in this PI isoform as well [31]. Based on these
results, the E. histolytica LPPG lipid anchors were assigned as 1-O-
(28:0)-lyso-glycero-3-phosphatidylinositol for EhPIa and 1-O-
[(28:0)-lyso-glycero-3-phosphatidyl-]2-O-(16:0)-inositol for EhPIb
(Fig. 4A). Interestingly, stimulation of lymphocytes in the presence
Figure 3. Structural characterization of the PI moieties of EhLPPG. (A) Thin-layer chromatography. Lane 1, PI from Sigma, lane 2 shows the
two isoforms EhPIa and EhPIb obtained after nitrous acid deamination ofEhPI. (B) EhPIs were analyzed by ESIFT-ICRMS. Negative ion mass spectrum of
EhPIa (upper) and EhPIb (lower). The [M]-26 corresponded to the exchange in the use of a 30:1 or a 28:1 fatty acid. EhPIs were further analyzed by ESI-
IRMPD. (C) Negative ion mass spectrum of the major parent ions found in EhPIa and EhPIb shown in (B).
doi:10.1371/journal.ppat.1000434.g003
E. histolytica Amebic liver abscess NKT
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that EhPIb, but not EhPIa, is the active portion of EhLPPG that
contains the capacity to induce the production of IFN-c (Fig. 4B).
EhLPPG activates NKT cells in a CD1d-restricted manner
To determine whether indeed NKT cells are responsible for
IFN-c secretion after stimulation with EhLPPG or EhPI,
lymphocytes were prepared from Ja18
2/2 or CD1d
2/2 mice
lacking iNKT or all NKT subpopulations, respectively, and co-
cultivated with EhLPPG- or EhPI-pulsed APC from wild-type
C57BL/6 mice. Cells from both Ja18
2/2 and CD1d
2/2 mice
revealed a strong reduction in IFN-c secretion, indicating that
iNKT cells represent the major source for IFN-c. To further
investigate CD1d-restriction of EhLPPG-mediated NKT-cell
activation, APC from wild type or CD1d
2/2 mice were pulsed
with a2GalCer, EhLPPG and EhPI, respectively, and co-
cultivated with purified T cells from liver or spleen of Va14 tg
mice (Fig. 5B). As expected, in contrast to APC from wild type
mice, APC from CD1d
2/2 mice were impaired in their ability to
activate NKT cells. Purified T cells incubated with a-GalCer,
EhLPPG and EhPI does not induce IFN-c in the abscence of APC
(data not shown). Taken together, these results suggest that
EhLPPG and in particular EhPI activates iNKT cells to produce
IFN-c in a CD1d restricted manner.
EhLPPG-induced NKT cell activation requires toll-like–
receptor 2/6 and functional IL-12
To determine whether CD1d-restricted iNKT cell activation by
EhLPPG requires the involvement of Toll-like-receptor (TLR)
Figure 4. Structure and NKT cell stimulatory capacity of EhPIs.
(A) The proposed structures of EhPIa (left) and EhPIb (right). The only
difference between the EhPIs is the acylation of inositol at position 2 in
EhPIb. The fatty acids and the molar ratios are indicated. (B) IFNc
production of NKT cells stimulated by APCs pulsed with a-GalCer,
EhLPPG, EhPI, EhPIa and EhPIb. IFN-c production compared to DMSO
control
*( p,0.05);
**( p,0.005); ANOVA, Dunnett. The results were
obtained from three independent experiments.
doi:10.1371/journal.ppat.1000434.g004
Figure 5. CD1d-restricted NKT cell activation by EhLPPG and
EhPI. (A) APC (5x10
4) from WT mice were pulsed with either 2 mgo fa-
GalCer, EhLPPG or EhPI and incubated with 1x10
5 lymphocytes of spleen
cell preparations from Ja 18
2/2 lacking iNKT cells and CD1d
2/2 mice
lacking iNKT and dNKT cells. IFN-c secretion was measured by ELISA.
Difference of IFN-c production in EhLPPG/EhPI activated WT splenocytes
*( p,0.05);
**( p,0.005),
***( p,0.001); ANOVA, Dunnett. (B) APC were
generated from either WT or CD1d
2/2 mice, pulsed as described above
and incubated with gradient purified liver lymphocytes from Va14-
transgenic mice. Liver iNKT cells were further purified by magnetic cells
sorting. IFN-c was assessed by ELISA. Difference of IFN-c production in
EhLPPG/EhPI activated WT splenocytes
*( p,0.05); student t test. The
results were obtained from three independent experiments.
doi:10.1371/journal.ppat.1000434.g005
E. histolytica Amebic liver abscess NKT
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adapter molecules MyD88 and TRIF, respectively, were pulsed
with EhLPPG or EhPI and co-cultivated with T cells from Va14 tg
mice (Va14iNKT). In addition, parallel experiments were per-
formed with APC from mice lacking TLR1, TLR2 or TLR6, or
with APC that are impaired to produce functional IL-12 (IL-
12p40
2/2) (Fig. 6). The results indicated that a TLR pathway other
than TLR3 is required for iNKT cell activation, as APC generated
from MyD88
2/2 but not from TRIF
2/2 mice were unable to
induce IFN-c by Va14iNKT cells.Moreover, thefindingthat IFN-c
isinducedbyAPCfromTLR1
2/2,butnotbythosegeneratedfrom
TLR2
2/2 and TLR6
2/2 mice suggested that EhLPPG or EhPI
were capable to activate APC by binding to TLR2, TLR6 or to
TLR2-TLR6 heterodimers. In addition to TLR2 and/or TLR6
signaling, iNKT cell activation by EhLPPG or EhPI required the
presence of functional IL-12, as APC from IL-12p40
2/2 mice were
incapable to induce IFN-c production by Va14iNKT cells.
We did not detect IL-4 in the supernatants of the co-culture
experiments using APC from the various knock-out mutants
pulsed with EhLPPG and iNKT cells (data not shown).
EhLPPG is internalized by APC
To gain more insight into the CD1d-restricted activation
process we performed several experiments to evaluate if EhLPPG
directly binds to CD1d without further processing. To this end
EhLPPG was incubated with plate bound CD1d and purified
NKT cells. However, no activation of NKT cells was observed.
Also CD1d-tetramer incubated with EhLPPG was unable to stain
NKT cells (data not shown). These data suggest that EhLPPG
cannot bind directly to CD1d molecules. In order to analyse
whether EhLPPG enter the endocytic pathway which would allow
further processing as a prerequisite for presentation on CD1d, we
performed immunofluorescence analysis using the monoclonal
anti-EhLPPG antibody EH5. Here we found that the ameba
lipopeptidophosphoglycan is internalized as anti-EH5 staining was
found to co-localize with Lamp-1 positive vesicles (Fig. 7A). Thus,
EhLPPG was targeted to lysosomes and/or late endosomes which
would allow processing and loading of the molecule to CD1d. To
corroborate this finding we inhibited the internalization and
processing of antigens by pre-incubation of APC with bafilomycin
A1, which interferes with the uptake of macromolecules in
endosomes [32]. The inhibition of endocytosis abrogated the
IFN-c production of NKT cells by EhLPPG and a-GalCer, but
not the IFN-c production induced by the TLR-specific activators
PamCys or LPS used as positive controls [33,34]. In addition the
incubation of antigen-pulsed APC with the mAb EH5, but not
with an isotype control (data not shown), inhibited the IFN-c
production of NKT cells in response to EhLPPG (Fig. 7B). This
may indicate that the mAb EH5 recognizes EhLPPG presented on
CD1d and thus prevented binding to the T cell receptor.
Collectively these data indicate that a processing of the EhLPPG
molecule is necessary to allow its presentation via CD1d.
EhLPPG treatment reduces the severity of ALA
To investigate whether EhLPPG similar to a-GalCer is able to
inhibit ALA development wildtype mice were treated with purified
EhLPPG 24 h prior to intrahepatic challenge with virulent E.
histolytica trophozoites. The results clearly indicate significant
protection in EhLPPG treated mice compared to respective
controls (Fig. 8).
Discussion
The majority of individuals infected with E. histolytica harbor the
parasite within the gut without any clinical signs of disease. Only a
small proportion may develop invasive amebaisis, e.g. amebic
colitis or amebic liver abscess (ALA). In this study we report on the
isolation and characterization of an E. histolytica lipopeptidopho-
sphoglycan (EhLPPG) that activates iNKT cells which were
previously shown to be crucial in the control of ALA in a mouse
model for disease [8]. EhLPPG was found to be a potent
stimulator of NKT cells to produce IFN-c, but not IL-4. Structural
characterization revealed that a particular phosphatidylinositol
(EhPI) isoform present within the GPI anchor of EhLPPG
constitutes the active component for IFN-c induction. Dissection
of the pathway involved in NKT cell activation indicated that
direct recognition of EhLPPG or EhPI presented on CD1d was
not sufficient for NKT cell activation, as it also required TLR
signaling and IL-12 production.
The importance of NKT cells for the control of ALA in vivo was
previously shown by the use of Ja 18
2/2 mice lacking iNKT cells
[8]and furtherconfirmed inthisstudybythefindingthatCD1d
2/2
mice lacking both iNKT and dNKT cells are more susceptible to
ALA development. In addition, application of the most potent and
specific NKT cell activator, a-GalCer reduced sizes of ALA
Figure 6. Activation of NKT cells by EhLPPG involves molecules
of the TLR signalling pathway. APC from IL12-p40
2/2, MyD88
2/2,
TRIF
2/2 (A), CD1d
2/2, TLR2
2/2,4
2/2,9
2/2 (B), and TLR1
2/2,2
2/2 and
6
2/2 (C) were generated, pulsed with EhLPPG and used to stimulate
purified T cells from Va14tg mice. The production of IFN-c by purifed T
cells was determined by ELISA. EhLPPG-dependent NKT cell activation
was abrogated in CD1d
2/2, IL-12p40
2/2, MyD88 and TLR 2
2/2 and TLR
6
2/2 mice. The results were obtained from two independent
experiments.
doi:10.1371/journal.ppat.1000434.g006
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or cryptococcusinfection have shown that a singletreatmentwitha-
GalCer rapidly stimulated IFN-c production by iNKT cells and
reduced parasite and bacterial burden, respectively [19,35,36].
EhLPPG, which is expressed on the surface of E. histolytica
trophozoites [20,23,27,37] was identified as the ameba molecule
that activates iNKT cells in vitro and which is able to reduce ALA
development when applied to mice prior to amebic challenge. To
this end we isolated the EhLPPG by an improvement of the
original method [26]. This method reduced the possibility of
contamination with phospholipids and small glycolipids that could
be co-extracted with LPPG and thus may interfere with/or
compete for the binding to CD1d, or may potentially provide an
indirect stimulus by ligation of TLR. A basic biochemical
characterization demonstrated the highly glycosylated nature of
the purified compound, which was further identified as EhLPPG
by its reactivity with the EhLPPG-specific monoclonal antibody
EH5 [28]. EhLPPG is structurally related to glycoconjugates
dominating the cell surfaces of other protozoa like Trypanosoma
brucei, T. cruzi, Leishmania and Plasmodium. Previous studies on
EhLPPG in which the structure was partially characterized
indicated the presence of the consensus sequence Gal1-
Man2GlcN-myo-inositol that corresponds to the core region of
GPI anchored molecules, although the nature and arrangement of
the lipid portion linked to the inositol moiety remained unclear
[27]. In the study presented, it is demonstrated that the EhLPPG is
in fact a GPI anchored molecule, applying biochemical degrada-
tion, gas chromatography and mass spectrometry of its PI
moieties. From these results it is concluded that E. histolytica
trophozoites posses two isoforms of PI, EhPIa and EhPIb,
respectively (Fig. 3A). In EhPIa, the glycerol is only substituted
at the sn-1 position by a single, long fatty acid chain (28:0 or 30:1),
Figure 7. EhLPPG is internalized and requires processing or endosomal trafficking for activation of NKT cells. (A) WT APC were pulsed
with 20 mg/ml EhLPPG for 3 h, fixed with 4% PFA and permeabilized with 0.5% saponin; EhLPPG was labeled with mAb EH5 [28] and anti Lamp-1
mAb was used for detection of late endosomes by confocal microscopy. The experiment was performed four times. (B) Treatment of APC with an
inhibitor of endocytosis, bafilomycin A1 (10 nM, 30 min), led to a decrease in the IFN-c production in NKT cells after stimulation with a-GalCer (4 mg/
ml) and EhLPPG (10 mg), but not with PamCys (4 mg/ml) and LPS (1 ng/ml). The addition of mAb EH5 (100 mg/ml) to APC pulsed with a-GalCer and
EhLPPG specifically inhibited the IFN-c secretion of cocultured NKT cells.
doi:10.1371/journal.ppat.1000434.g007
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substitution with 28:0 or 30:1 at the sn-1 of glycerol but
interestingly had an additional 16:0 in the inositol ring, which is
not a common feature among protozoa [39], although it was
found in Plasmodium falciparum GPI [40] and in T. brucei PARP GPI,
where the glycerol is monoacylated as well as the inositol is
substituted by 16:0 [41]. This non-common fatty acid distribution
might confer particular biological properties to EhLPPG in the
interaction with components of the innate immune system like
CD1d molecules. These molecules belong to a family of major
histocompatibility antigen-like molecules that bind gycophosphi-
nositol with a high affinity and regulate the function and
differentiation of NKT cells [42].
In vitro stimulation of APC by EhLPPG induced secretion of
IFN-c by NKT cells. However, compared to a-GalCer, stimula-
tion with EhLPPG was significantly weaker, similar to levels
obtained with glycolipid preparations from other microorganisms
such as bacteria or protozoa [16–18]. The strong induction of
IFN-c by a-GalCer might be due to the composition and length of
the alkyl (C26:0) and sphingosine (C18:0) chains, which appear to
be optimal for CD1d binding [43]. On the other hand and in
contrast to a-GalCer, EhLPPG did not induce secretion of IL-4.
Although the mechanism for the induction of IL-4 is not well
understood, a recent investigation suggested that the length of the
lipid chain plays an essential role since the truncation of the
sphingosine chain promoted the induction of IL-4 and triggered a
Th2 immune response [44].
Activation of iNKT cells due to microbial infections can be
achieved through direct or indirect pathways (for rev. see [10]).
The direct, cognate or antigen mediated activation requires the
uptake of the glycolipid, processing and subsequent loading to
CD1d molecules in the endosomes of the APC. In this scenario,
iNKT cells are engaged via their invariant TCR recognizing
antigen presented on CD1d without any contribution of additional
cytokines released from the APC. Beside a-GalCer as the classical
direct activator of iNKT cells, glycolipids from various bacteria or
protozoa have the capacity to activate NKT cells by CD1d
restriction independent from cytokines provided by the APC [15–
18]. For indirect or adjuvant-like activation of iNKT cells,
different possible pathways have been proposed. One of the
indirect pathways involves the recognition of PAMPS by TLR
resulting in the induction of IL-12 and/or IL-18 activating NKT
cells in a CD1d-independent manner [45]. During Salmonella
typhimurium infection, the NKT cell response depends on IL-12 and
additionally on CD1d recognition [46]. Another activation
mechanism has been described for LPS which induces IFN-c
production in NKT cells via IL-12 and IL- [34]. A third
alternative is an indirect activation pathway induced by parasite
eggs. Here endogenous glycolipid is upregulated by a yet unknown
mechanism and presented via CD1d to NKT cells. So far, this
mechanism has been described only for DCs sensitized with eggs
from Schistosoma mansoni [47]. From the results presented here using
a series of knock-out mice we conclude that activation of iNKT
cells by EhLPPG or EhPI requires both presentation of EhPI by
CD1d as well as TLR signalling and IL-12 production.
In addition, we provide evidence that endocytosis and
processing of EhLPPG is a prerequisite for CD1d-dependent
NKT cell activation since i) we could not find a direct binding of
EhLPPG to recombinant CD1d, ii) EhLPPG was found to co-
localize with Lamp-1 as a marker for late endosomes which would
allow processing and loading of the molecule to CD1d and iii) we
showed that NKT cell activation is abrogated when APC
endocytosis was inhibited by bafilomycin [48]. In addition, the
incubation of APC with the mAb EH5 inhibited the IFN-c
production of NKT cells in response to EhLPPG. The finding that
induction of IFN-c by APC from TLR2
2/2 and TLR6
2/2 mice is
abrogated suggests that EhLPPG and EhPI is capable to activate
the APC by binding through these TLR. This is in agreement with
recent results that diacylated motifs, as also present in the active
EhPIb isoform, bind to TLR2-TLR6 heterodimers, while
triacylated molecules engage TLR2-TLR1 heterodimers [49,50].
However, we can not exclude that the inability of EhLPPG and
recombinant CD1d to stimulate NKT cells is due to a lack of
costimulatory molecules and/or cytokines. Moreover, the lack of
direct binding of EhLPPG to CD1d might indicate that the
observed activation of NKT cells by EhLPPG also involves an
increased presentation of self-antigens by CD1d.
Interestingly, we did not find activity with the monoacylated
EhPIa isoform, although such a structure is in principle capable to
activate NKT cells via TLR2 and CD1d dependent pathways as
shown for a structurally related LPG from Leishmania [15,51]. In
consideration of an adjuvant effect of TLR-ligands during
activation of CD1d-restricted NKT cell, traces of contaminating
lipopeptides could also be responsible for the TLR2-dependent
response [52]. However, the double extraction method (chloro-
form methanol water and phenol water) used for the purification
of EhLPPG should minimize the risk of contamination [53].
Our data demonstrate that early IFN-c production by NKT
cells is responsible for a sufficient control of parasites in the liver.
In addition, NKT cells provide a link between innate and adaptive
immunity due to their capacity to early produce large amounts of
IFN-c and IL-4 that can bias the immune response into either a
TH1-or TH2 direction. The exclusive IFN-c production of
EhLPPG activated NKT cells can be expected to trigger the
subsequent adaptive immune response into a TH1 type that would
provide additional IFN-c. This might augment efficient abcess
control by T cell dependent mechanisms at later time points.
Taken together the results presented here indicate that EhLPPG
is able to limit ALA development most likely due to its ability to
specifically activate iNKT cells to produce IFN-c. The importance
of IFN-c for the control of E. histolytica has been documented in
Figure 8. Development of ALA in EhLPPG treated mice. 24 h
prior to intrahepatic challenge with virulent E. histolytica trophozoites,
WT mice were treated with 4 mg EhLPPG by i.p. application. Seven days
post infection, mice were sacrificed and sizes of abscesses were
determined. Shown are sizes of ALA in EhLPPG treated mice relative to
untreated controls. Results were obtained from 2 independent
experiments comprising 5 to 6 animals each (statistics: Mann-Whitney
U test).
doi:10.1371/journal.ppat.1000434.g008
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model used in this study recently revealed that the application of
IFN-c - neutralizing antibodies abrogates ALA development. Thus
EhLPPG constitutes an ameba molecule that is critically important
to control ALA and which might be responsible for the lack of
amebic disease in the majority of E. histolytica infected individuals.
Materials and Methods
Cultivation of E. histolytica
Trophozoites of the E. histolytica isolate HM-1:IMSS were grown
axenically in TYI-S-3 medium [55]. To maintain virulence,
trophozoites were regularly passaged through the liver of C57BL/
6 mice as described previously [8].
Origin of mice
Wild-type C57BL/6 (WT),Va14-Ja18transgenic(tg),TLR1
2/2,
TLR6
2/2, CD1d
2/2 and Ja18
2/2 were bred and housed under
specific pathogen-freeconditionsat the BernhardNocht Institute for
Tropical Medicine (Hamburg). IL12p40
2/2;T L R 2
2/2 and
MyD88
2/2 were kindly provided by Christoph Ho ¨lscher, Research
Center Borstel, Germany. TRIF
2/2 were kindly provided by Bruce
Beutler, La Jolla, California. All mice were backcrossed on a B6
genetic background for .10 generations.
Experimental amebic liver abscess and treatment with a-
GalCer
Amebic liver abscesses were induced by direct intrahepatic
inoculation of virulent E. histolytica trophozoites as previously
described [56] with minor modifications for the use of C57BL/6
mice [8]. The influence of a-GalCer and EhLPPG on the abscess
formation was investigated by intraperitoneal application of 2 mg
a-GalCer (Alexis, Axxora) or 4 mg EhLPPG diluted in PBS/0.05%
Tween 20 per animal 24 h prior to amebic challenge. In our
previous work we found that abscesses are self-limited and were
resolved until day 21 post infection. Performing a kinetic analysis
of abcess formation we found that day seven post infection is the
most appropriate time point for studying the influence of immune
mechanisms on abcess size [8]. Therefore, on day seven post
intrahepatic inoculation of E. histolytica trophozoites, the animals
were sacrificed and the size of the abscess lesions were measured in
mm, a score was introduced and related to the score of ALA found
in WT mice (score: 0= no abscess; 1=,1 mm; 2=1–5 mm;
3=.5 mm).
Isolation of EhLPPG and its phosphatidylinositol (EhPI)
moiety
Trophozoites of the late logarithmic phase of growth were
washed, resuspended in pyrogen free water and lysed by freeze
and thawing. The homogenate was centrifuged at 430 g at 4uC for
10 min and subsequently the supernatant was recovered and
ultracentrifuged at 150,000 g for 40 min [57]. The obtained pellet
was extracted with a mixture of chloroform/methanol/water
10:10:3 (by volume) and the insoluble material was recovered by
centrifugation, dried, resuspended in distilled pyrogen free water
and extracted three times with an equal volume of 90% phenol at
68uC for 30 min with constant stirring [58]. The water phase
containing EhLPPG was recovered after centrifugation at 12,000 g
for 30 min and dialysis against distilled water. In order to obtain
the EhPI moiety, nitrous acid deamination was performed as
described [59]. In brief, dried EhLPPG was resuspended in a
mixture of 0.3 M sodium acetate buffer at pH 4.0 and 1 M
sodium nitrite, incubated at 37uC for 2 h. The released EhPI
moiety was recovered from the organic phase after partition
between water and water-saturated 1-butanol. The organic phase
was then dried under a stream of nitrogen and resuspended in a
mixture of chloroform/methanol/water 10:10:3 (by volume) for
analysis on Silica Gel 60 high-performance thin-layer chromatog-
raphy (HPTLC) plates. EhPIa and EhPIb were separated on a
preparative HPTLC and re-extracted with a mixture of Chloro-
form/methanol/water 10:10:3 (by volume). For the use in cell
stimulation, PI, PIa and PIb were dried under a stream of nitrogen
and resuspened in PBS/Tween (0.05%). EhLPPG and EhPI
samples contained ,0.25 endotoxin units (EU) per ml at the
concentrations used for cell activation, as determined by the
Limulus amoebocyte lysate assays (Cambrex).
Immunochemical and spectroscopic analysis
EhLPPG (10 mg/lane) was analyzed by 12% SDS-PAGE and
either stained to evidence the presence of protein (Coomassie
brilliant blue) and carbohydrates (silver nitrate and periodic acid
Schiff), or transferred to a PVDF membrane for Western blot
analysis and subsequently developed with the LPPG-specific
monoclonal antibody EH5 [28]. For compositional analyses,
EhLPPG and EhPI were subjected to methanolysis. 150 mlo f
0.5 M hydrochloric acid in dry methanol was added and the
solution incubated at 85uC for 1 h, followed by addition of 50 ml
of both pyridine and acetic anhydride and analyzed by GC-MS on
a Hewlett Packard GL 5890 Gas chromatograph equipped with
an Ultra-1 column (Agilent) and coupled to an electron impact
mass detector.
Electrospray Ionization Fourier Transform Ion Cyclotron Mass
Spectrometry (ESI FT-ICR MS) was performed in the negative
ion mode using an APEX Qe – Instrument (Bruker Daltonics,
Billerica, USA) equipped with a 7 Tesla actively shielded magnet.
Mass spectra were acquired using standard experimental sequenc-
es as provided by the manufacturer. Samples were dissolved at a
concentration of ,10 ng/ml in a 50:50:0.001 (v/v/v) mixture of 2-
propanol, water, and triethylamine and sprayed at a flow rate of
2 ml/min. Capillary entrance voltage was set to 3.8 kV, and dry
gas temperature to 150uC.
Infrared-multiphoton dissociation (IRMPD) of isolated parent
ions was performed with a 35 W, 106 mmC O 2 laser (Synrad,
Mukilteo, WA). The unfocused laser beam was directed through
the center of the ICR cell and fragment ions were detected after a
delay of 0.5 ms. The duration of laser irradiation was adapted for
each sample to generate optimal fragmentation and varied
between 10–80 ms.
Generation of APC
Bone marrow was harvested from femurs of 6- to 10-week-old
mice and cultured as described by Lutz et al. [60]. Cultures were
supplemented with supernatants from Ag8653 myeloma cells
transfected with the gene coding for murine GM-CSF (kindly
provided by B. Stockinger, NMRI, Mill Hill, London, UK). The
percentage of mature cells was determined by FACS analysis using
anti- CD11c - APC, anti - CD40-FITC, anti - CD86-PE or anti -
CD80 (BD-Bioscience) and ranged from 20–23%.
Isolation of cells from spleen and liver
Spleens were perfused with hypotonic ammonium chlorid
solution for erythrolysis. Subsequently, cells were washed twice
with medium and adjusted to the appropriate number. Livers were
perfused with ice cold PBS/20% FCS solution and subsequently
filtered through a 40 mm mesh. Following centrifugation at 400 g,
cell pellets were resuspended in RPMI-20 medium, underlayed
with a 30% Nycodenz solution (Nycoprep
TM, Universal) and
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collected from the interface, treated with hypotonic ammonium
chloride solution, washed and subjected to magnetic bead sorting
using the Pan T-cell isolation kit (Macs, Myltenyi). NKT-cell
populations were analyzed for purity by flow cytometry using a-
GalCer (Alexis; Axora) loaded CD1d-tetramer-PE (Proimmune)
and anti-CD4-FITC (BD Bioscience). Purified NKT cells did not
produce IFN-c after cultivation with a-GalCer in the abscence of
aditional APC.
Co-culture of APC with NKT cells isolated from spleen or
liver
BMDC were used as antigen presenting cells (APC). In brief,
4610
4 cells/well were cultured in triplicates in 96-well round
bottom plates with RPMI-20 medium, supplemented with FCS, L-
glutamine, antibiotics, sodium pyruvate. The cells were pulsed
with a-GalCer or purified amebic EhLPPG or EhPI at indicated
concentrations for 3 h. NKT-cell enriched spleen and liver
lymphocytes were then added to the pulsed APC with 1610
5
cells/well and incubated for 24 h (IL-4) and 48 h (IFN-c).
Cytokines were measured with the respective sandwhich ELISA
for IL-4 and IFN-c (R&D System). To block the processing and
presentation pathway, APCs were treated with 10 nM bafilomycin
A1 (Sigma) 30 min before incubation with EhLPPG, a-GalCer,
PamCys-SKK (EMC, Germany) or LPS (E. coli, serotype 055:B5;
SIGMA). In an additional set of experiments APC were pulsed for
3 h with EhLPPG or a-GalCer. Subsequently APC were
incubated with 100 mg/ml mAb EH5 [28] before the addition of
NKT cells.
Intracellular localization of EhLPPG
APC from WT BL6 mice were pulsed with 20 mg/ml of
EhLPPG and seeded in 24-well plates with glass coverslips and
incubated with 5%CO2 at 37uC for 3 h. Subsequently, cells were
washed, fixed with 4% paraformaldehyde and permeabilized with
0.5% saponin (Sigma). Intracellular EhLPPG was stained with
mouse-monoclonal antibody EH5 [28] followed by Alexa 594
labeled anti-mouse IgG (Invitrogen). The internalized EhLPPG
colocalized with a rat anti- CD107a/LAMP-1 Mab (Southern
Biotec) and Alexa 488 labelled anti-rat IgG (Invitrogen). Nuclei
were stained with 4`,6`-diamidino-2-phenylindole hydrochloride
(DAPI). All stainings were visualized with a Leica DRM confocal
microscope and OpenLab software (Improvison. Inc).
Statistics
Statistics were performed using Prism statistical software
(GraphPad) unpaired, one-way, non parametric Mann-Whitney
U tests, the ANOVA, Dunnett and the student t test.
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